Details of the Drug

General Information of Drug (ID: DMXJ683)

Drug Name

KY1044

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1/2	[1]
------------------------------------------------------------------------------------

Drug Type

Antibody

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Inducible T-cell costimulator (ICOS)	TTE5VP6	ICOS_HUMAN	Inhibitor	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT03829501) Safety and Efficacy of KY1044 and Atezolizumab in Advanced Cancer. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of Kymab.